← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 Immix Biopharma IMMX $720M	12	-6	-33%	$730K
102	102 MiNK Therapeutics INKT $50.7M	12	-4	-25%	$1.15M
103	ONCS 103 DELISTED OncoSec Medical Incorporated ONCS	12	-5	-29%	$665K
104	104 Eterna Therapeutics ERNA $2.53M	10	-1	-9%	$1.14M
105	CYAD 105 DELISTED Celyad Oncology SA American Depositary Shares CYAD	8	0	0%	$6.29M
106	106 Estrella Immunopharma ESLA $23.3M	8	-5	-38%	$8.09M
107	107 Coya Therapeutics COYA $102M	7	+3	+75%	$4.37M
108	KRBP 108 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	7	-5	-42%	$78.2K
109	RUBY 109 DELISTED Rubius Therapeutics, Inc RUBY	7	-35	-83%	$61.3K
110	110 NewcelX Ltd NCEL $16.5M	6	+2	+50%	$9.62M
111	SIOX 111 DELISTED Sio Gene Therapies Inc. Common Stock SIOX	4	-33	-89%	$1.13M
112	TCBP 112 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	3	+2	+200%	$207K
113	113 Genenta Science GNTA $32.3M	2	-2	-50%	$274K
114	SCPS 114 DELISTED Scopus BioPharma Inc. Common Stock SCPS	0	-1	-100%	$0
115	AGTC 115 DELISTED Applied Genetic Technologies Corporation AGTC	–	–	–	–
116	AKUS 116 DELISTED Akouos Inc AKUS	–	–	–	–
117	117 Artiva Biotherapeutics ARTV $296M	–	–	–	–
118	118 DELISTED CARGO Therapeutics CRGX	–	–	–	–
119	119 enGene Therapeutics ENGN $115M	–	–	–	–
120	120 FibroBiologics FBLG $7.08M	–	–	–	–
121	121 CytoMed Therapeutics GDTC $10.4M	–	–	–	–
122	122 Fractyl Health GUTS $55.2M	–	–	–	–
123	123 Kyverna Therapeutics KYTX $369M	–	–	–	–
124	LOGC 124 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	–	–	–	–
125	125 Lexeo Therapeutics LXEO $227M	–	–	–	–